Introduction: Prior to 2015 there was no pathway for adrenal masses. An Adrenal MDT was started to discuss all the adrenal nodules (except for suspected phaechromocytoma and adrenal carcinoma) to improve the service for this cohort of patients. This audit is a review of the impact of this intervention.
Methods: Data was collected between April 2016 and March 2016 for all adrenalectomies performed at East Sussex Hospitals Trust. Data was collected from the TheatreMan surgical database.
Results: 27 patients had had Adrenalectomy surgery. 6 patients (22%) had adrenalectomy for functioning adrenal lesions: 2 with Conns syndrome, 1 patient with adrenal Cushings, 2 patients with Subclinical Cushing (probable autonomous cortisol secretion) and 1 patient has had combined aldosterone and steroid secreting lesion. Only 2 out of the 4 patients with adrenal cortisol secretion has had appropriate steroid cover during the perioperative period. 3 patients (11%) were found to have metastatic adrenal lesions and 18 patients (67%) had adrenalectomy as part of Radical nephrectomy for renal cell carcinoma.
Conclusion: We plan to introduce guidelines for steroid management for all steroid secreting adrenal tumours in perioperative period.